Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
TNFRSF14 (TNF Receptor Superfamily Member 14)
i
Other names:
TNFRSF14, TNF Receptor Superfamily Member 14, HVEA, HVEM, TR2, Tumor Necrosis Factor Receptor Superfamily, Member 14 (Herpesvirus Entry Mediator), Tumor Necrosis Factor Receptor Superfamily Member 14, Herpes Virus Entry Mediator A, LIGHTR, CD270, ATAR, Tumor Necrosis Factor Receptor Superfamily, Member 14, Tumor Necrosis Factor Receptor-Like Gene2, Tumor Necrosis Factor Receptor-Like 2, Herpesvirus Entry Mediator A, Herpesvirus Entry Mediator, CD40-Like Protein, CD270 Antigen, HveA
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
8764
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
TNFRSF14 mutation
Hodgkin Lymphoma
TNFRSF14 mutation
Hodgkin Lymphoma
sintilimab
Resistant: C3 – Early Trials
sintilimab
Resistant
:
C3
sintilimab
Resistant: C3 – Early Trials
sintilimab
Resistant
:
C3
TNFRSF14 overexpression
Non Small Cell Lung Cancer
TNFRSF14 overexpression
Non Small Cell Lung Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
TNFRSF14 expression
Solid Tumor
TNFRSF14 expression
Solid Tumor
TAB004
Sensitive: C3 – Early Trials
TAB004
Sensitive
:
C3
TAB004
Sensitive: C3 – Early Trials
TAB004
Sensitive
:
C3
TNFRSF14 overexpression
Soft Tissue Sarcoma
TNFRSF14 overexpression
Soft Tissue Sarcoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.